» Articles » PMID: 28215833

Effects of Platelet-rich Plasma Against Experimental Ischemia/reperfusion Injury in Rat Testis

Overview
Journal J Pediatr Urol
Publisher Elsevier
Specialties Pediatrics
Urology
Date 2017 Feb 21
PMID 28215833
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Testicular torsion is a common problem and, to date, there is no agent to preserve testicular function following detorsion. Platelet-rich plasma (PRP), with its rich growth factor composition, has proven beneficial in regenerative therapy. It is believed that PRP has not been studied in testis for ischemia/reperfusion (I/R) injury.

Objective: This study investigated the effect of PRP in an I/R rat model 1 month after detorsion.

Study Design: Of 24 adult male Sprague-Dawley rats, 18 were randomly assigned into three groups, with six in each: control, I/R and I/R + PRP. The PRP was prepared from the remaining six. Each group underwent right orchiectomy. Ischemia was performed by rotating the left testis 720° and fixing with a nylon suture for 4 h. Reperfusion occurred 4 h later by removing the suture, and PRP was administered at a dose of 10 μl (2000 × 10/l) into the left testis via the intraparenchymal route. Animals were sacrificed at the fourth week, and testes were taken for malondialdehyde (MDA), glutathione (GSH), superoxide dismutase (SOD), myeloperoxidase (MPO), transforming growth factor β (TGF-β), and caspase-3 measurements.

Results: Ischemia/reperfusion caused a significant increase in MDA, MPO and caspase-3 activity, and significant decrease in GSH levels and SOD activity. The PRP treatment helped correct the alterations in SOD, caspase-3, and MPO activities and MDA levels. However, the mean MDA level and MPO activity were not totally restored compared with the controls. Serum testosterone levels of the I/R group were significantly lower compared with the control and I/R + PRP groups. TGF-β and caspase-3 protein expressions were significantly higher in the I/R group compared with the control group and were low with PRP administration compared with I/R groups (summary Table).

Discussion: The findings of the present study suggest that PRP, by inhibiting neutrophil infiltration and oxidative stress and increasing antioxidant defense, exerts protective effects on testicular tissues against I/R. This study had some limitations: a scoring system was not used in the assessment of spermatogenesis in the histopathological findings and specific testis cell types were not histologically assessed.

Conclusions: In light of the biochemical, histological and, especially, hormonal findings, intraparenchymal PRP injection may have a protective effect in testicular tissue against I/R injury.

Citing Articles

The Effect of Scrotal PRP Injection on Testes Function and Spermatogenesis Resumed in Azoospermia Mice Model Caused by Chronic Hyperthermia.

Babolhekami H, Ebrahimzadeh-Bideskan A, Eshtad E, Karimi S Reprod Sci. 2025; .

PMID: 40032806 DOI: 10.1007/s43032-025-01824-8.


Clinical efficacy of intracavernous injection of platelet lysate for erectile dysfunction.

Chang Y, Chiang I, Chang H, Chen Y, Jeff Chueh S BMC Urol. 2024; 24(1):237.

PMID: 39472866 PMC: 11520801. DOI: 10.1186/s12894-024-01633-2.


Comparison of the therapeutic effect of platelet-rich plasma and injectable platelet-rich fibrin on testicular torsion/detorsion injury in rats.

Eisa E, Ezzeldein S, Mohammed H, Abdallah A, Ghonimi W, Raouf M Sci Rep. 2024; 14(1):18045.

PMID: 39103420 PMC: 11300838. DOI: 10.1038/s41598-024-67704-4.


Platelet-rich plasma attenuates the UPEC-induced cystitis via inhibiting MMP-2,9 activities and downregulation of NGF and VEGF in Canis Lupus Familiaris model.

Abdelgalil A, Yassin A, Khattab M, Abdelnaby E, Marouf S, Farghali H Sci Rep. 2024; 14(1):13612.

PMID: 38871929 PMC: 11176177. DOI: 10.1038/s41598-024-63760-y.


How Does Platelet-Rich Plasma Injection in Ovaries of Poor Responders Affect the Retrieved Oocytes, and Anti Mullerian Hormone: A Clinical Trial.

Tehraninejad E, Razavi M, Tarafdari Menshadi A, Shariat M, Shahsavari S, Haghollahi F J Family Reprod Health. 2024; 17(3):165-173.

PMID: 38716292 PMC: 11070746. DOI: 10.18502/jfrh.v17i3.13539.